Svexa's Dr Euan Ashley interviewed about his new book - "The Genome Odyssey". AVAILABLE NOW!

As we announced recently, Svexa's Co-Founder & Chairman of the Board Dr Euan Ashley has released his book The Genome Odyssey: Medical Mysteries and the Incredible Quest to Solve Them. The book is AVAILABLE NOW, BUY IT TODAY!

Euan was recently interviewed by Celadon Books discussing how his team, including several Svexa colleagues, developed their world leading approaches to precision medicine. They explore the world of opportunities that are unlocked by the rapid availability of the complete unique genome for each patient.


Available to buy now in all good book sellers, the book brings the breakthroughs of precision medicine to vivid life through the real diagnostic journeys of his patients and the tireless efforts of his fellow doctors and scientists as they hunt to prevent, predict, and beat disease.

"Given all the gloom, here's a wholeheartedly positive book about the future of medicine. The science is thrilling, the hope & compassion compelling, as Euan Angus Ashley lays out the astonishing advances in our application of the human genome to medicine."

- former UK Prime Minister David Cameron

"The Genome Odyssey is destined to be a landmark narrative in the canon of modern science... Ashley's prose is brilliant and makes for compelling reading"

- Abraham Verghese, author of Cutting for Stone


Euan is Associate Dean and Professor of Cardiovascular Medicine and Genetics at Stanford University in California.  His research focuses on genetic mechanisms of cardiovascular health and disease.  In addition to wet bench science, his laboratory leverages artificial intelligence and digital health tools, working with biotechnology and technology partners in Silicon Valley, to advance both translational and clinical research.

Euan has received many awards including recognition from the Obama White House for contributions to personalized medicine and the American Heart Association’s Medal of Honor for precision medicine. The efforts and improvements in clinical precision medicine that his team leads worldwide is a foundational pillar in Svexa's work in precision health and individualized optimization of training and performance.